Corebridge Financial’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34,440	Closed	-$95.1K	–	2509
2025 Q1	$95.1K	Sell	34,440 -511	-1%	-$1.41K	﹤0.01%	2464
2024 Q4	$194K	Buy	34,951 +4,169	+14%	+$23.1K	﹤0.01%	2205
2024 Q3	$257K	Sell	30,782 -190	-0.6%	-$1.59K	﹤0.01%	2076
2024 Q2	$211K	Buy	+30,972	New	+$211K	﹤0.01%	2161